Form 4: Oscar Health Director Receives Deferred Stock Units

Oscar Health director David Plouffe received 1,461 deferred stock units on April 9, 2026, as part of a compensation plan.

Summary

• David Plouffe, a Director at Oscar Health, Inc., was granted 1,461 deferred stock units (DSUs) on April 9, 2026.
• These DSUs represent a right to receive one share of the Issuer's Class A common stock.
• The DSUs were received in lieu of cash retainer payments for his board service, as per the Issuer's Deferred Compensation Plan for Directors.
• The number of DSUs was calculated based on the closing price of Oscar Health's Class A common stock on April 9, 2026, which was $14.54 per share.
• These units will be settled in cash or shares within 45 days of specific events, including termination of service, change in control, death, or disability.
• DSUs issued in lieu of cash retainer payments are fully vested on the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it details a standard compensation transaction for a director rather than providing new financial performance or strategic information.

Positives

• Director compensation aligns with stock value, indicating confidence in the company's stock price.
• The use of deferred stock units can incentivize long-term commitment from directors.
• Vesting on grant date for DSUs in lieu of cash retainer provides immediate benefit to the director.

Negatives

• The filing does not contain any negative financial or operational information.

Risks

• The value of the deferred stock units is subject to the fluctuation of Oscar Health's Class A common stock price.
• Settlement of DSUs is contingent on future events such as termination of service, change in control, death, or disability.

Future Outlook

The future outlook is not directly addressed in this filing, which focuses on a specific compensation event for a director.

Management Comments

• The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors.

Industry Context

StockSavvy.ai notes that the issuance of deferred stock units to directors is a common practice in the healthcare and technology sectors, aligning executive and director interests with shareholder value.

Corporate Governance

Related Party Transactions

• Grant of 1,461 deferred stock units to Director David Plouffe in lieu of cash retainer payments.

Stakeholder Impact

• Shareholders: The issuance of stock units can dilute ownership slightly but also aligns director incentives with stock performance.
• Directors: Provides a form of compensation tied to the company's stock value.
• Employees: No direct impact mentioned.

Next Steps

• Settlement of deferred stock units for cash or shares within 45 days of specific triggering events (termination of service, change in control, death, or disability).

Key Dates

Keywords

Oscar Health, OSCR, Form 4, Deferred Stock Units, Director Compensation, SEC Filing, Insider Trading, Equity Compensation